Opinion
2012-1576 2012-1601 2012-1602 2012-1603 2012-1604 2012-1605 2012-1607
10-17-2012
PFIZER INC., WARNER-LAMBERT COMPANY LLC, AND CP. PHARMACEUTICALS INTERNATIONAL C.V., Plaintiffs-Appellees, AND NORTHWESTERN UNIVERSITY, Plaintiff-Appellee, v. TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellants, AND LUPIN, LTD. AND LUPIN PHARMACEUTICALS, INC., Defendan ts-Appellants, AND ACTAVIS, INC. AND ACTAVIS ELIZABETH, LLC, Defendants-Appellants, AND COBALT LABORATORIES, INC. AND COBALT PHARMACEUTICALS, INC., Defendants-Appellants, AND SUN PHARMA GLOBAL, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., AND SUN PHARMACEUTICAL INDUSTRIES, INC., Defendants-Appellants, AND WOCKHARDT LIMITED and WOCKHARDT USA, LLC, Defendants-Appellants, AND ALPHAPHARM PTY. LTD. AND MYLAN PHARMACEUTICALS, INC., Defendants-Appellants.
NOTE: This order is nonprecedential.
Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0307, Chief Judge Gregory M. Sleet.
ON MOTION
ORDER
The parties jointly move for an extension of 31 days, until November 19, 2012, for the appellants to file their principal briefs and 46 days, until February 15, 2013, for appellees to file their responsive brief.
Upon consideration thereof,
IT IS ORDERED THAT:
The motion is granted.
FOR THE COURT
_________________
Jan Horbaly
Clerk
s27